Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SELP | P16109 | 2/20 | 0.55 |
| ▸ | SELL | P14151 | 2/20 | 0.55 |
| ▸ | SIGLEC7 | Q9Y286 | 6/20 | 0.48 |
| ▸ | MAG | P20916 | 5/20 | 0.48 |
| ▸ | SELE | P16581 | 5/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18162892 | 0.95 | SELP (0.54) | SELPSELLSIGLEC7MAGSELE | |
| SCHEMBL18162894 | 0.95 | SELP (0.54) | SELPSELLSIGLEC7MAGSELE | |
| SCHEMBL18166213 | 0.95 | SELP (0.54) | SELPSELLSIGLEC7MAGSELE | |
| SCHEMBL18166208 | 0.95 | SELP (0.54) | SELPSELLSIGLEC7MAGSELE | |
| SCHEMBL16409445 | 0.93 | SELP (0.54) | SELPSELLSIGLEC7MAGSELE | |
| SCHEMBL17988584 | 0.90 | SELP (0.54) | SELPSELLSIGLEC7MAGSELE | |
| SCHEMBL16326756 | 0.89 | MAG (0.51) | SELPSELLSIGLEC7MAGSELE | |
| SCHEMBL16326667 | 0.89 | MAG (0.51) | SELPSELLSIGLEC7MAGSELE | |
| SCHEMBL15215717 | 0.88 | SELP (0.56) | SELPSELLSIGLEC7MAGSELE | |
| SCHEMBL17903220 | 0.88 | SELP (0.64) | SELPSELLSIGLEC7MAGSELE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170072037-A1 | Xenoantigen-Displaying Anti-Cancer Vaccines and Method of Making | THE UNIVERSITY OF TOLEDO (US) | 2017-03-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170072037-A1 | Xenoantigen-Displaying Anti-Cancer Vaccines and Method of Making | CSGALNACT1, B3GAT3, LGALS3BP | SELP 241/4885SELL 545/4885SIGLEC7 18/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.